Rubicon's Generic Cevimeline Hydrochloride Receives Approval in the U.S.
Drug firm LupinBSE -0.21 % has received final approval from the US health regulator to market cevimeline hydrochloride capsules, used for treatment of symptoms of dry mouth in patients with Sjogren's syndrome, in the US market.
Novel's Generic Cevimeline Hydrochloride Receives Approval In US